By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Announces Oral Presentation At 2014 Chemotherapy Foundation Symposium 10/30/2014 8:50:24 AM
CytRx Corporation (CYTR) Announces Publication Of Preclinical Glioblastoma Data In Neoplasia 10/29/2014 7:53:29 AM
CytRx Corporation (CYTR) Announces Publication Of Phase 1b/2 Aldoxorubicin Clinical Data In Soft Tissue Sarcoma In Cancer, The Peer-Reviewed Journal Of The American Cancer Society 10/20/2014 7:16:51 AM
CytRx Corporation (CYTR) To Present Data From Global Phase 2b Clinical Trial Of Aldoxorubicin In First-Line Soft Tissue Sarcoma At 2014 CTOS Annual Meeting 10/17/2014 7:21:00 AM
CytRx Corporation (CYTR) Appoints Steven A. Kriegsman As Chairman Of The Board 10/16/2014 7:28:16 AM
CytRx Corporation (CYTR) Launches Discovery Laboratory To Develop Albumin-Binding Anti-Cancer Drug Platform 10/13/2014 7:31:30 AM
CytRx Corporation (CYTR) Initiates Phase 1b Clinical Trial With Combination Of Aldoxorubicin And Gemcitabine In Patients With Metastatic Solid Tumors 10/9/2014 7:44:52 AM
CytRx Corporation (CYTR) Initiates Global Phase 2b Clinical Trial Of Aldoxorubicin For The Treatment Of Relapsed/Refractory Small Cell Lung Cancer 9/30/2014 8:07:55 AM
CytRx Corporation (CYTR) Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer 9/29/2014 8:55:44 AM
CytRx Corporation (CYTR) Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas And Global Phase 2b Small Cell Lung Cancer Trial Designs At ESMO 2014 Congress 9/22/2014 7:34:00 AM